These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28760668)

  • 1. RIG-I Activation Protects and Rescues from Lethal Influenza Virus Infection and Bacterial Superinfection.
    Coch C; Stümpel JP; Lilien-Waldau V; Wohlleber D; Kümmerer BM; Bekeredjian-Ding I; Kochs G; Garbi N; Herberhold S; Schuberth-Wagner C; Ludwig J; Barchet W; Schlee M; Hoerauf A; Bootz F; Staeheli P; Hartmann G; Hartmann E
    Mol Ther; 2017 Sep; 25(9):2093-2103. PubMed ID: 28760668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual Effect of Organogermanium Compound THGP on RIG-I-Mediated Viral Sensing and Viral Replication during Influenza a Virus Infection.
    Baidya S; Nishimoto Y; Sato S; Shimada Y; Sakurai N; Nonaka H; Noguchi K; Kido M; Tadano S; Ishikawa K; Li K; Okubo A; Yamada T; Orba Y; Sasaki M; Sawa H; Miyamoto H; Takada A; Nakamura T; Takaoka A
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duox2 is required for the transcription of pattern recognition receptors in acute viral lung infection: An interferon-independent regulatory mechanism.
    Hong SN; Kim JY; Kim H; Kim DY; Won TB; Han DH; Rhee CS; Kim HJ
    Antiviral Res; 2016 Oct; 134():1-5. PubMed ID: 27546489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
    Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
    J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination.
    Koyama S; Ishii KJ; Kumar H; Tanimoto T; Coban C; Uematsu S; Kawai T; Akira S
    J Immunol; 2007 Oct; 179(7):4711-20. PubMed ID: 17878370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFI16 directly senses viral RNA and enhances RIG-I transcription and activation to restrict influenza virus infection.
    Jiang Z; Wei F; Zhang Y; Wang T; Gao W; Yu S; Sun H; Pu J; Sun Y; Wang M; Tong Q; Gao C; Chang KC; Liu J
    Nat Microbiol; 2021 Jul; 6(7):932-945. PubMed ID: 33986530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIG-I overexpression decreases mortality of cigarette smoke exposed mice during influenza A virus infection.
    Wang X; Wu W; Zhang W; Leland Booth J; Duggan ES; Tian L; More S; Zhao YD; Sawh RN; Liu L; Zou MH; Metcalf JP
    Respir Res; 2017 Sep; 18(1):166. PubMed ID: 28865477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RIG-I Signaling Is Critical for Efficient Polyfunctional T Cell Responses during Influenza Virus Infection.
    Kandasamy M; Suryawanshi A; Tundup S; Perez JT; Schmolke M; Manicassamy S; Manicassamy B
    PLoS Pathog; 2016 Jul; 12(7):e1005754. PubMed ID: 27438481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion.
    Mahmoud AB; Tu MM; Wight A; Zein HS; Rahim MM; Lee SH; Sekhon HS; Brown EG; Makrigiannis AP
    PLoS Pathog; 2016 Feb; 12(2):e1005446. PubMed ID: 26928844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists.
    Chiang C; Beljanski V; Yin K; Olagnier D; Ben Yebdri F; Steel C; Goulet ML; DeFilippis VR; Streblow DN; Haddad EK; Trautmann L; Ross T; Lin R; Hiscott J
    J Virol; 2015 Aug; 89(15):8011-25. PubMed ID: 26018150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice.
    Abdul-Careem MF; Firoz Mian M; Gillgrass AE; Chenoweth MJ; Barra NG; Chan T; Al-Garawi AA; Chew MV; Yue G; van Roojen N; Xing Z; Ashkar AA
    Antiviral Res; 2011 Nov; 92(2):346-55. PubMed ID: 21945041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness.
    Galani IE; Triantafyllia V; Eleminiadou EE; Koltsida O; Stavropoulos A; Manioudaki M; Thanos D; Doyle SE; Kotenko SV; Thanopoulou K; Andreakos E
    Immunity; 2017 May; 46(5):875-890.e6. PubMed ID: 28514692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Interferon-Stimulated Genes Correlates with Reduced Growth of Influenza A Virus in Lungs after RIG-I Agonist Treatment of Ferrets.
    Schwab LSU; Londrigan SL; Brooks AG; Hurt AC; Sahu A; Deng YM; Moselen J; Coch C; Zillinger T; Hartmann G; Reading PC
    J Virol; 2022 Aug; 96(16):e0055922. PubMed ID: 35916513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a Functional Mx1 Protein Is Essential for the Ability of RIG-I Agonist Prophylaxis to Provide Potent and Long-Lasting Protection in a Mouse Model of Influenza A Virus Infection.
    Schwab LSU; Villalón-Letelier F; Tessema MB; Londrigan SL; Brooks AG; Hurt A; Coch C; Zillinger T; Hartmann G; Reading PC
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early regulation of viral infection reduces inflammation and rescues mx-positive mice from lethal avian influenza infection.
    Song MS; Cho YH; Park SJ; Pascua PN; Baek YH; Kwon HI; Lee OJ; Kong BW; Kim H; Shin EC; Kim CJ; Choi YK
    Am J Pathol; 2013 Apr; 182(4):1308-21. PubMed ID: 23395090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standing on three legs: antiviral activities of RIG-I against influenza viruses.
    Weber-Gerlach M; Weber F
    Curr Opin Immunol; 2016 Oct; 42():71-75. PubMed ID: 27318973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Proteolytic Activation of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by Different Type II Transmembrane Serine Proteases.
    Kühn N; Bergmann S; Kösterke N; Lambertz RLO; Keppner A; van den Brand JMA; Pöhlmann S; Weiß S; Hummler E; Hatesuer B; Schughart K
    J Virol; 2016 May; 90(9):4298-4307. PubMed ID: 26889029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate Immune Sensing of Influenza A Virus.
    Malik G; Zhou Y
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32674269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection.
    Marx S; Kümmerer BM; Grützner C; Kato H; Schlee M; Renn M; Bartok E; Hartmann G
    Mol Ther Nucleic Acids; 2022 Mar; 27():1225-1234. PubMed ID: 35186439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The innate immunity of guinea pigs against highly pathogenic avian influenza virus infection.
    Zhang K; Xu WW; Zhang Z; Liu J; Li J; Sun L; Sun W; Jiao P; Sang X; Ren Z; Yu Z; Li Y; Feng N; Wang T; Wang H; Yang S; Zhao Y; Zhang X; Wilker PR; Liu W; Liao M; Chen H; Gao Y; Xia X
    Oncotarget; 2017 May; 8(18):30422-30437. PubMed ID: 28418930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.